Free Trial

Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Lmcg Investments LLC

Doximity logo with Medical background

Lmcg Investments LLC trimmed its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 21.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 118,397 shares of the company's stock after selling 31,537 shares during the period. Lmcg Investments LLC owned about 0.06% of Doximity worth $6,871,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Shaker Investments LLC OH bought a new stake in shares of Doximity in the 4th quarter worth approximately $559,000. Principal Financial Group Inc. boosted its position in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock valued at $15,695,000 after purchasing an additional 4,282 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new stake in shares of Doximity during the fourth quarter valued at approximately $362,000. Stratos Wealth Partners LTD. purchased a new position in Doximity during the fourth quarter valued at $203,000. Finally, Wells Fargo & Company MN raised its stake in Doximity by 3.3% during the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock valued at $19,698,000 after buying an additional 11,811 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Price Performance

Shares of DOCS stock traded up $1.49 during trading on Friday, hitting $58.83. 2,014,061 shares of the stock traded hands, compared to its average volume of 2,129,029. The firm has a market capitalization of $11.05 billion, a P/E ratio of 58.83, a price-to-earnings-growth ratio of 4.10 and a beta of 1.32. The firm's fifty day moving average price is $54.72 and its 200-day moving average price is $58.29. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company's quarterly revenue was up 17.1% compared to the same quarter last year. During the same period last year, the business earned $0.25 EPS. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Mizuho decreased their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. JPMorgan Chase & Co. dropped their price objective on Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. Truist Financial decreased their target price on Doximity from $58.00 to $52.00 and set a "hold" rating on the stock in a research report on Friday, May 16th. Needham & Company LLC decreased their price objective on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research report on Friday, May 16th. Finally, KeyCorp decreased their price objective on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Eleven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $62.84.

Read Our Latest Stock Report on DOCS

Insider Buying and Selling at Doximity

In other Doximity news, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now owns 357,165 shares in the company, valued at $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now owns 16,618 shares of the company's stock, valued at approximately $946,062.74. This trade represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,000 shares of company stock valued at $2,900,770 over the last quarter. 37.40% of the stock is owned by company insiders.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines